top of page

ARTICLES

Publications

Paul R. Michel & Matthew J. Dowd, America’s Innovators Need Clear Patent Laws, Wall Street Journal (Jan. 24, 2020), available here.

Robert J. Scheffel & Matthew J. Dowd, Issues To Watch In Fed. Circ. Hep C Drug Patent Case, Law360 (June 7, 2019), available here.  

Matthew J. Dowd & Jonathan Stroud, Will Fed. Circ. Consider The Competitor Standing Doctrine?, Law360 (Dec. 18, 2018), available here.

Matthew J. Dowd & Jonathan Stroud, Standing to Appeal at the Federal Circuit: Appellants, Appellees, and Intervenors, 74 Catholic University Law Review 661 (2018), available here.

Hon. Paul R. Michel (ret.) & Matthew J. Dowd, Innovation and Patent Policy, CPI Antitrust Chronicle (June 2018), available here.

Hon. Paul R. Michel (ret.) & Matthew J. Dowd, Consensus Grows that US Patent System Needs a Lifeline, IAM (Sept. 2017)  (Available here).

Matthew J. Dowd, Banning Rule 36 Affirmances: Be Careful What You Ask For, Law360 (Aug. 2017) (link).

 

Matthew J. Dowd, Fed. Circ. Is Permitted To Use Rule 36 For USPTO Appeals, Law360 (Mar. 2017) (link).

 

Hon. Paul R. Michel (ret.) & Matthew J. Dowd, Understanding the Errors of eBay, The Criterion Journal on Innovation (Feb. 2017).  The article can be viewed here.

 

Hon. Paul R. Michel & Matthew J. Dowd, The Uncertain State of Patent Law 10 Years Into The Roberts Court, IAM Magazine (Oct. 2016) (link)

Matthew J. Dowd (co-author), The Limited Impact of Provisional Patent Rights, Law360 (Feb. 11, 2016) (link)

Matthew J. Dowd, How to Take Advantage of New Federal Circuit Brief Structure, Law360 (Jan. 8, 2014) (link)

Matthew J. Dowd, Conversations with Two Chief Judges, Medical Innovation & Business (Summer 2010) - Interview of former Chief Judge Paul Michel and then-Chief Judge Randall R. Rader (link

Matthew J. Dowd (co-author), In i4i v. Microsoft, Federal Circuit Affirms Damages, Injunctions, and Other Issues, 22 Intellectual Property & Technology Law Journal (Mar. 2010) (link)

Matthew J. Dowd (co-author), Panacea or Poison Pill? Making Sense of the New Biosimilars Law, 8 BNA Pharm. L. & Indus. Rep. 698 (2010).

Matthew J. Dowd (co-author), Reexamination Practice with Concurrent District Court or USITC Patent Litigation, 9 Sedona Conference Journal 53 (2008). 

Matthew J. Dowd (co-author), KSR International Co. v. Teleflex Inc.: Another Small Issue for Nanotechnology?, 4 Nanotechnology Law & Business 293 (2007) (co-author) (link)

Matthew J. Dowd No Claim Adjudication Without Representation: A Criticism of 38 U.S.C. § 5904(c), 16 Federal Circuit Bar Journal 53 (2006) (link)

bottom of page